⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 17, 2024Open Access

Figure S6 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network

Michaela Poliaková Turan Rahel Riedo Matúš Medo Chiara Pozzato Manja Friese‐Hamim Jonas P. Koch Si’Ana A. Coggins Qun Li Baek Kim Joachim Albers Daniel M. Aebersold Nicola Zamboni Yitzhak Zimmer Michaela Medová

View Full Paper

Ask AI

Bookmark

Share

Abstract

GART protein expression upon MAPK and PI3K targeting: GART protein levels in untreated GTL-16 and EBC-1 cells and after MAPK (AZD6244) and PI3K (LY294002) pathways inhibition. ß Actin was used as a loading control.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Turan et al. (2024) studied this question.

synapsesocial.com/papers/68e5833db6db643587520e54 https://doi.org/10.1158/2767-9764.27045887

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S5 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network2024
2Figure 3 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network2024
3Table S2 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network2024
4Table S2 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network2024
5Table S2 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network2024